Clean Biologics, an international group providing services to the biopharmaceutical industry, appointed Laurent Claisse as chief executive officer.  Claisse succeeds Joseph Jammal, who served for five years and strengthened group activities, including the operational framework of its subsidiary Clean Cells. Under Jammal’s tenure, Clean Biologics advanced its standing as a leading European expert in quality control services for developers of biotherapies. Reflecting on his tenure, former CE...